Breaking News

West Receives CE Mark for ID Adapter

By Kristin Brooks | February 24, 2014

Designed to help improve consistency and reliability of intradermal injections

West Pharmaceutical Services, Inc. has received CE approval of its Intradermal (ID) Adapter, which is designed to help improve the consistency and reliability of intradermal injections. The approval is based on two clinical studies that verified the performance of the ID adapter.
According to the company, correctly administered ID injections can help conserve the supply of high-value vaccines and provide patients with a more reliable injection. The ID Adapter provides an alternative to the Mantoux method, which has been the industry standard since 1907, and requires extensive training and experience to perform correctly and consistently. According to the company, the ID Adapter enables this process to be carried out more easily, with less training and with greater reliability.
"We are delighted to offer our European customers a solution which can improve reliability and performance of intradermal injections and meet growing market demands in this area," said Zach Marks, marketing director, Pharmaceutical Delivery Systems.

blog comments powered by Disqus
  • Cryogenic Cold Chain Risk Mitigation

    Cryogenic Cold Chain Risk Mitigation

    Kristin Brooks, Contract Pharma||November 13, 2015
    Mark Sawicki of Cryoport explains the requirements, challenges, and regulatory aspects around cryogenic logistics

  • A Biologic Innovator

    A Biologic Innovator's Pursuit to Uphold Patents

    Kristin Brooks, Contract Pharma||October 12, 2015
    Amgen v. Sandoz biosimilars litigation could impact the industry for years to come

  • 2015 Contracting & Outsourcing Wrap-up

    2015 Contracting & Outsourcing Wrap-up

    Kristin Brooks, Contract Pharma||September 30, 2015
    A huge success, with another year of record attendance, sold-out exhibit hall, and a great line up of informative sessions

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Getting Real

    Michael Pollock, PPD||November 17, 2015
    Partnering for clinical and real-world evidence studies

  • Bringing Transparency and Collaboration to CRO Oversight

    Bringing Transparency and Collaboration to CRO Oversight

    Craig Morgan , goBalto Inc. ||November 17, 2015
    Relationships between sponsors and CROs are getting stronger